Search results (158)
« Back to PublicationsCore outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE).
Journal article
Yacoub S. et al, (2026), Lancet Infect Dis, 26, e231 - e244
Accurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019.
Journal article
Wongnak P. et al, (2026), J Infect Dis, 233, e582 - e584
Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Journal article
Schilling WHK. et al, (2026), Lancet Infect Dis, 26, 139 - 147
Evaluating anti-infective drugs for acute illness: the legacy of Professor Sir Nicholas White
Journal article
Watson JA. and Schilling WHK., (2026), PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 381
Evaluating 12 automated, whole-genome sequencing analysis pipelines for Mycobacterium tuberculosis complex: a comparative study.
Journal article
Spies R. et al, (2025), Lancet Microbe, 6
Pharmacometric evaluation of sulfadoxine-pyrimethamine- amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda.
Journal article
Bonnington C. et al, (2025), Clin Infect Dis
Probabilistic classification of late treatment failure in uncomplicated falciparum malaria.
Journal article
Mehra S. et al, (2025), Nat Commun, 16
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.
Journal article
Esmaeili S. et al, (2025), J Clin Invest, 135
Deaths from febrile coma in African children can be reduced now.
Journal article
White NJ. et al, (2025), Lancet Glob Health, 13
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials.
Journal article
Watson JA. et al, (2025), Lancet Microbe, 6
Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings.
Journal article
White NJ. and Watson JA., (2025), Lancet Infect Dis
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA).
Journal article
Assmus F. et al, (2025), PLoS Negl Trop Dis, 19
Risk stratification of childhood infection using host markers of immune and endothelial activation in Asia (Spot Sepsis): a multi-country, prospective, cohort study.
Journal article
Chandna A. et al, (2025), Lancet Child Adolesc Health, 9, 634 - 645
